Previous 10 | Next 10 |
BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisition of Evolution Health, LLC, a provider of home health services. Evolution Health, LLC, a di...
BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice, personal care and high-acuity care, has closed on its acquisition of certain home health assets from AssistedCare Home Health, Inc., and RH Homecare Servic...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
BATON ROUGE, La., March 08, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chris Gerard, President and Chief Operating Officer, and Scott Ginn, Executive Vice President and...
BATON ROUGE, La., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and C...
Amedisys (AMED +5.5%) has stretched its post-earnings gains further on Friday after BMO Capital Markets upgraded the healthcare services firm on the strength of its 2022 outlook and compelling valuation. Baton Rouge, Louisiana-based Amedisys (NASDAQ:AMED) reported better-than-anticipated Q4 2...
Amedisys, Inc. (AMED) Q4 2021 Earnings Conference Call February 24, 2022 11:00 AM ET Company Participants Nick Muscato - Senior Vice President-Finance Paul Kusserow - Chairman and Chief Executive Officer Christopher Gerard - President and Chief Operating Officer Scott Ginn - Executive Vice Pr...
The following slide deck was published by Amedisys, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Amedisys, Inc. 2021 Q4 - Results - Earnings Call Presentation
Amedisys press release (NASDAQ:AMED): Q4 Non-GAAP EPS of $1.18 in-line. Revenue of $559.32M (+1.6% Y/Y) beats by $4.14M. For FY2022, the company expects adjusted diluted EPS in the range of $5.23 to $5.45 based on an estimated 33.2M shares outstanding vs. consensus of $5.84. For furthe...
BATON ROUGE, La., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2021. Three-Month Periods Ended December 31, 2021 and 2020 Net service revenue increased $8...
News, Short Squeeze, Breakout and More Instantly...
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024. Three-Month Periods Ended June 30, 2024 and 2023 Net service revenue increased $38.2 million to...
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Amedisys, Inc. (NASDAQ: AMED) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 3.74% on the day to $95.23. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates thr...